Concepedia

Riccardo Ferracini

RF

Statistics

Publications

73

Citations

3.6K

H-Index

34

Active since

1984

Affiliations

University of Turin(Current)

Azienda Ospedaliero Universitaria San Giovanni Battista

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino

University of Genoa

Ospedale Policlinico San Martino

Riccardo Ferracini is an author at University of Turin specializing in medicine, cell biology, and orthopaedics.

ORCID

Top concepts

Publications per year

1984–2024

73

Publications

73

The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.

Riccardo Ferracini, Maria Flavia Di Renzo, Katia Scotlandi et al. · PubMed · 1995 · 284 citations

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib

Roberto Piva, Bruce Ruggeri, Michael Williams et al. · Blood · 2007 · 252 citations · Full text

The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation.

Luigi Naldini, Elisa Vigna, Riccardo Ferracini et al. · Molecular and Cellular Biology · 1991 · 185 citations · Full text

, , +15

Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase.

Riccardo Ferracini, Paola Longati, Luigi Naldini et al. · Journal of Biological Chemistry · 1991 · 144 citations · Full text

<i>MET</i> Overexpression Turns Human Primary Osteoblasts into Osteosarcomas

Salvatore Patanè, Sofia Avnet, Nadia Coltella et al. · Cancer Research · 2006 · 129 citations · Full text

1–5 of 73